Andrew Yee, MD, is Clinical Director of the Center for Multiple Myeloma at Massachusetts General Hospital Cancer and Assistant Professor of Medicine at Harvard Medical School. He attended Harvard Medical School, trained in internal medicine at Massachusetts General Hospital, and then specialized in hematology and medical oncology at Dana-Farber Cancer Institute. He focuses on multiple myeloma and also sees patients with plasma cell disorders including monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and AL amyloidosis. He is the principal investigator on several trials in multiple myeloma, including multiple investigator-initiated trials.